Literature DB >> 23129759

Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment.

Juliane Doerrbecker1, Patrick Behrendt, Pedro Mateu-Gelabert, Sandra Ciesek, Nina Riebesehl, Corinne Wilhelm, Joerg Steinmann, Thomas Pietschmann, Eike Steinmann.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) transmission among people who inject drugs remains a challenging public health problem. We investigated the risk of HCV transmission by analyzing the direct association of HCV with filters, water to dilute drugs, and water containers.
METHODS: Experiments were designed to replicate practices by people who inject drugs and include routinely used injection equipment. HCV stability in water was assessed by inoculation of bottled water with HCV. Viral association with containers was investigated by filling the containers with water, inoculating the water with HCV, emptying the water, and refilling the container with fresh water. Transmission risk associated with drug preparation filters was determined after drawing virus through a filter and incubating the filter to release infectious particles.
RESULTS: HCV can survive for up to 3 weeks in bottled water. Water containers present a risk for HCV transmission, as infectious virions remained associated with water containers after washing. Physical properties of the water containers determined the degree of HCV contamination after containers were refilled with water. HCV was also associated with filter material, in which around 10% of the viral inoculum was detectable.
CONCLUSIONS: This study demonstrates the potential risk of HCV transmission among injection drug users who share water, filters, and water containers and will help to define public health interventions to reduce HCV transmission.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23129759      PMCID: PMC3611766          DOI: 10.1093/infdis/jis677

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  39 in total

Review 1.  Mother-to-infant transmission of hepatitis C virus.

Authors:  L T Yeung; S M King; E A Roberts
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

Review 2.  Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment.

Authors:  Enrique R Pouget; Holly Hagan; Don C Des Jarlais
Journal:  Addiction       Date:  2012-04-17       Impact factor: 6.526

3.  Inactivation and survival of hepatitis C virus on inanimate surfaces.

Authors:  Juliane Doerrbecker; Martina Friesland; Sandra Ciesek; Thomas J Erichsen; Pedro Mateu-Gelabert; Jörg Steinmann; Jochen Steinmann; Thomas Pietschmann; Eike Steinmann
Journal:  J Infect Dis       Date:  2011-10-19       Impact factor: 5.226

4.  Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention.

Authors:  Stephen Koester; Jason Glanz; Anna Barón
Journal:  AIDS Behav       Date:  2005-03

Review 5.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

Authors:  Paul K Nelson; Bradley M Mathers; Benjamin Cowie; Holly Hagan; Don Des Jarlais; Danielle Horyniak; Louisa Degenhardt
Journal:  Lancet       Date:  2011-07-27       Impact factor: 79.321

6.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

7.  An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic.

Authors:  Alexandre Macedo de Oliveira; Kathryn L White; Dennis P Leschinsky; Brady D Beecham; Tara M Vogt; Ronald L Moolenaar; Joseph F Perz; Thomas J Safranek
Journal:  Ann Intern Med       Date:  2005-06-07       Impact factor: 25.391

8.  Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.

Authors:  Thomas Pietschmann; Artur Kaul; George Koutsoudakis; Anna Shavinskaya; Stephanie Kallis; Eike Steinmann; Karim Abid; Francesco Negro; Marlene Dreux; Francois-Loic Cosset; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

9.  Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles.

Authors:  Eike Steinmann; Christiane Brohm; Stephanie Kallis; Ralf Bartenschlager; Thomas Pietschmann
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

Review 10.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

View more
  31 in total

1.  Development, validation, and potential applications of the hepatitis C virus injection-risk knowledge scale (HCV-IRKS) among young opioid users in New York City.

Authors:  Kelly Quinn; Chunki Fong; Honoria Guarino; Pedro Mateu-Gelabert
Journal:  Drug Alcohol Depend       Date:  2018-11-28       Impact factor: 4.492

2.  Patterns of drug use, risky behavior, and health status among persons who inject drugs living in San Diego, California: a latent class analysis.

Authors:  Alexis M Roth; Richard A Armenta; Karla D Wagner; Scott C Roesch; Ricky N Bluthenthal; Jazmine Cuevas-Mota; Richard S Garfein
Journal:  Subst Use Misuse       Date:  2014-10-14       Impact factor: 2.164

3.  "Money Helps": People who inject drugs and their perceptions of financial compensation and its ethical implications.

Authors:  Roberto Abadie; Brandon Brown; Celia B Fisher
Journal:  Ethics Behav       Date:  2018-11-05

Review 4.  Global control of hepatitis C: where challenge meets opportunity.

Authors:  David L Thomas
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

Review 5.  Hepatitis C virus vaccines among people who inject drugs.

Authors:  Andrea L Cox; David L Thomas
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

6.  Opioid Use Trajectories, Injection Drug Use, and Hepatitis C Virus Risk Among Young Adult Immigrants from the Former Soviet Union Living in New York City.

Authors:  Honoria Guarino; Lisa A Marsch; Sherry Deren; Shulamith L A Straussner; Anastasia Teper
Journal:  J Addict Dis       Date:  2015

7.  Mechanisms of methods for hepatitis C virus inactivation.

Authors:  Stephanie Pfaender; Janine Brinkmann; Daniel Todt; Nina Riebesehl; Joerg Steinmann; Jochen Steinmann; Thomas Pietschmann; Eike Steinmann
Journal:  Appl Environ Microbiol       Date:  2014-12-19       Impact factor: 4.792

8.  A comparison of seminal hepatitis C virus (HCV) RNA levels during recent and chronic HCV infection in HIV-infected and HIV-uninfected individuals.

Authors:  Daniel Bradshaw; Francois Lamoury; Beth Catlett; Tanya L Applegate; John Mcallister; Gregory J Dore; Gail V Matthews; Mark Danta
Journal:  J Infect Dis       Date:  2014-10-06       Impact factor: 5.226

9.  Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics.

Authors:  Jon E Zibbell; Rachel Hart-Malloy; John Barry; Lillian Fan; Colleen Flanigan
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

10.  Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.

Authors:  David Otiashvili; Gvantsa Piralishvili; Zura Sikharulidze; George Kamkamidze; Sabrina Poole; George E Woody
Journal:  Drug Alcohol Depend       Date:  2013-07-31       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.